Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$165.67 - $199.94 $50,529 - $60,981
305 Added 20.27%
1,810 $306,000
Q3 2023

Nov 13, 2023

SELL
$167.14 - $192.77 $17,549 - $20,240
-105 Reduced 6.52%
1,505 $261,000
Q2 2023

Aug 14, 2023

BUY
$160.94 - $186.23 $259,113 - $299,830
1,610 New
1,610 $277,000
Q2 2022

Aug 15, 2022

BUY
$155.97 - $200.09 $5,147 - $6,602
33 Added 2.58%
1,311 $225,000
Q1 2022

May 17, 2022

SELL
$181.39 - $234.03 $22,673 - $29,253
-125 Reduced 8.91%
1,278 $241,000
Q4 2021

Feb 18, 2022

BUY
$193.69 - $247.03 $271,747 - $346,583
1,403 New
1,403 $342,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.7B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Future Fund LLC Portfolio

Follow Future Fund LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Future Fund LLC, based on Form 13F filings with the SEC.

News

Stay updated on Future Fund LLC with notifications on news.